Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety of Ancestral Monovalent BNT162b2, mRNA-1273, and NVX-CoV2373 COVID-19 Vaccines in US Children Aged 6 Months to 17 Years.
Hu M, Shoaibi A, Feng Y, Lloyd PC, Wong HL, Smith ER, Amend KL, Kline A, Beachler DC, Gruber JF, Mitra M, Seeger JD, Harris C, Secora A, Obidi J, Wang J, Song J, McMahill-Walraven CN, Reich C, McEvoy R, Do R, Chillarige Y, Clifford R, Cooper DD, Forshee RA, Anderson SA. Hu M, et al. Among authors: beachler dc. JAMA Netw Open. 2024 Apr 1;7(4):e248192. doi: 10.1001/jamanetworkopen.2024.8192. JAMA Netw Open. 2024. PMID: 38656578 Free PMC article.
Background rates of adverse events of special interest for COVID-19 vaccine safety monitoring in the United States, 2019-2020.
Moll K, Lufkin B, Fingar KR, Ke Zhou C, Tworkoski E, Shi C, Hobbi S, Hu M, Sheng M, McCarty J, Shangguan S, Burrell T, Chillarige Y, Beers J, Saunders-Hastings P, Muthuri S, Edwards K, Black S, Kelman J, Reich C, Amend KL, Djibo DA, Beachler D, Ogilvie RP, Secora A, McMahill-Walraven CN, Seeger JD, Lloyd P, Thompson D, Dimova R, MaCurdy T, Obidi J, Anderson S, Forshee R, Wong HL, Shoaibi A. Moll K, et al. Vaccine. 2023 Jan 9;41(2):333-353. doi: 10.1016/j.vaccine.2022.11.003. Epub 2022 Nov 8. Vaccine. 2023. PMID: 36404170 Free PMC article.
Safety of the BNT162b2 COVID-19 Vaccine in Children Aged 5 to 17 Years.
Hu M, Wong HL, Feng Y, Lloyd PC, Smith ER, Amend KL, Kline A, Beachler DC, Gruber JF, Mitra M, Seeger JD, Harris C, Secora A, Obidi J, Wang J, Song J, McMahill-Walraven CN, Reich C, McEvoy R, Do R, Chillarige Y, Clifford R, Cooper DD, Shoaibi A, Forshee R, Anderson SA. Hu M, et al. Among authors: beachler dc. JAMA Pediatr. 2023 Jul 1;177(7):710-717. doi: 10.1001/jamapediatrics.2023.1440. JAMA Pediatr. 2023. PMID: 37213095 Free PMC article.
Incidence rates of thrombosis with thrombocytopenia syndrome (TTS) among adults in United States commercial and Medicare claims databases, 2017-2020.
Lloyd PC, Lufkin B, Moll K, Ogilvie RP, McMahill-Walraven CN, Beachler DC, Kelman JA, Shi X, Hobbi S, Amend KL, Djibo DA, Shangguan S, Shoaibi A, Sheng M, Secora A, Zhou CK, Kowarski L, Chillarige Y, Forshee RA, Anderson SA, Muthuri S, Seeger JD, Kline A, Reich C, MaCurdy T, Wong HL. Lloyd PC, et al. Among authors: beachler dc. Vaccine. 2024 Mar 19;42(8):2004-2010. doi: 10.1016/j.vaccine.2024.02.017. Epub 2024 Feb 22. Vaccine. 2024. PMID: 38388240
Comparative safety of conjugated estrogens/bazedoxifene versus estrogen/progestin combination hormone therapy among women in the United States: a multidatabase cohort study.
Hoffman SR, Governor S, Daniels K, Seals RM, Ziyadeh NJ, Wang FT, Dai D, Mcmahill-Walraven CN, Shuminski P, Frajzyngier V, Zhou X, Shen R, Garg RK, Fournakis N, Lanes S, Beachler DC. Hoffman SR, et al. Among authors: beachler dc. Menopause. 2023 Aug 1;30(8):824-830. doi: 10.1097/GME.0000000000002217. Epub 2023 Jul 11. Menopause. 2023. PMID: 37449720 Free PMC article.
Risk of Anaphylaxis Among New Users of GLP-1 Receptor Agonists: A Cohort Study.
Anthony MS, Aroda VR, Parlett LE, Djebarri L, Berreghis S, Calingaert B, Beachler DC, Crowe CL, Johannes CB, Juhaeri J, Lanes S, Pan C, Rothman KJ, Saltus CW, Walsh KE. Anthony MS, et al. Among authors: beachler dc. Diabetes Care. 2024 Apr 1;47(4):712-719. doi: 10.2337/dc23-1911. Diabetes Care. 2024. PMID: 38363873 Free PMC article.
Liver, renal, genitourinary and diabetic ketoacidosis risks among new users of empagliflozin versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: Post-authorization safety study based on multinational cohorts.
Rebordosa C, Thomsen RW, Tave AK, Madsen M, Beachler DC, Martinez D, Garcia-Esteban R, Plana E, Tormos A, Farsani SF, Perez-Gutthann S, Pladevall-Vila M. Rebordosa C, et al. Among authors: beachler dc. Diabetes Obes Metab. 2024 Apr;26(4):1291-1304. doi: 10.1111/dom.15429. Epub 2024 Jan 17. Diabetes Obes Metab. 2024. PMID: 38234181
Validation to correct for outcome misclassification bias.
Lanes S, Beachler DC. Lanes S, et al. Among authors: beachler dc. Pharmacoepidemiol Drug Saf. 2023 Jun;32(6):700-703. doi: 10.1002/pds.5601. Epub 2023 Feb 23. Pharmacoepidemiol Drug Saf. 2023. PMID: 36751117 No abstract available.
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting.
Danysh HE, Johannes CB, Beachler DC, Layton JB, Ziemiecki R, Arana A, Dinh J, Li L, Calingaert B, Pladevall-Vila M, Hunt PR, Chen H, Karlsson C, Johnsson K, Gilsenan A. Danysh HE, et al. Among authors: beachler dc. Drug Saf. 2023 Feb;46(2):175-193. doi: 10.1007/s40264-022-01262-4. Epub 2022 Dec 30. Drug Saf. 2023. PMID: 36583828 Free PMC article.
51 results